1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Nielsen, K.J.
Thomas, L.
Lewis, R.J.
Alewood, P.F.
Craik, D.J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
H2 N
16.023
AMINO GROUP
non-polymer
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
263
297
310
10.1006/jmbi.1996.0576
8913308
A consensus structure for omega-conotoxins with different selectivities for voltage-sensitive calcium channel subtypes: comparison of MVIIA, SVIB and SNX-202.
1996
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
2750.234
SVIB
1
man
polymer
OMEGA-CONOTOXIN SVIB
no
yes
CKLKGQSCRKTSYDCCSGSCGRSGKC(NH2)
CKLKGQSCRKTSYDCCSGSCGRSGKCX
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
striated cone
Conus
sample
6493
Conus striatus
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conf
struct_conf_type
repository
Initial release
Version format compliance
Version format compliance
Derived calculations
Other
1
0
1997-08-12
1
1
2008-03-24
1
2
2011-07-13
1
3
2017-11-29
_pdbx_database_status.process_site
Y
BNL
1996-08-02
REL
REL
LOW E AND FEW VIOLATIONS OF EXPERIMENTAL RESTRAINTS
50
15
NOESY
TOCSY
DQF-COSY
E-COSY
3.
293
K
CHARM22 A TOTAL OF 50 INITIAL STRUCTURES WERE CALCULATED USING A SIMULATED ANNEALING PROGRAM AS SUPPLIED WITH X-PLOR 3.1. THE FINAL 20 STRUCTURES WITH THE LOWEST OVERALL ENERGIES AND FEWEST VIOLATIONS OF NOE AND DIHEDRAL RESTRAINTS WERE ENERGY MINIMIZED IN X-PLOR USING THE CHARMM FORCEFIELD [BROOKS ET AL. (1983) J. COMPUT. CHEM., VOL. 4 187-217.]
MD/SIMULATED ANNEALING
BRUNGER
refinement
X-PLOR
3.1
structure solution
X-PLOR
500
Bruker
ARX
CYS
1
n
1
CYS
1
A
LYS
2
n
2
LYS
2
A
LEU
3
n
3
LEU
3
A
LYS
4
n
4
LYS
4
A
GLY
5
n
5
GLY
5
A
GLN
6
n
6
GLN
6
A
SER
7
n
7
SER
7
A
CYS
8
n
8
CYS
8
A
ARG
9
n
9
ARG
9
A
LYS
10
n
10
LYS
10
A
THR
11
n
11
THR
11
A
SER
12
n
12
SER
12
A
TYR
13
n
13
TYR
13
A
ASP
14
n
14
ASP
14
A
CYS
15
n
15
CYS
15
A
CYS
16
n
16
CYS
16
A
SER
17
n
17
SER
17
A
GLY
18
n
18
GLY
18
A
SER
19
n
19
SER
19
A
CYS
20
n
20
CYS
20
A
GLY
21
n
21
GLY
21
A
ARG
22
n
22
ARG
22
A
SER
23
n
23
SER
23
A
GLY
24
n
24
GLY
24
A
LYS
25
n
25
LYS
25
A
CYS
26
n
26
CYS
26
A
NH2
27
n
27
NH2
27
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
GLY
21
A
N
GLY
21
A
O
LYS
25
A
O
LYS
25
A
O
GLY
24
A
O
GLY
24
A
N
CYS
8
A
N
CYS
8
1
7.14
1.10
114.20
121.34
A
A
A
CA
CB
SG
CYS
CYS
CYS
8
8
8
N
3
7.58
1.10
114.20
121.78
A
A
A
CA
CB
SG
CYS
CYS
CYS
8
8
8
N
1
A
SER
19
-161.19
-39.75
1
A
CYS
20
-16.35
122.03
1
A
ARG
22
-95.45
34.54
1
A
SER
23
77.48
39.26
2
A
THR
11
73.79
-16.18
3
A
TYR
13
54.49
19.67
3
A
SER
17
-69.58
0.85
4
A
CYS
8
-160.07
-168.71
4
A
LYS
10
-48.87
152.73
4
A
THR
11
49.56
16.41
4
A
TYR
13
54.53
17.96
4
A
ARG
22
-95.42
33.19
4
A
SER
23
59.83
83.38
6
A
SER
12
-154.12
51.88
6
A
TYR
13
-24.45
-57.17
6
A
CYS
20
-19.94
135.14
6
A
ARG
22
-95.28
32.02
6
A
SER
23
61.26
74.03
7
A
THR
11
58.37
8.37
7
A
SER
17
-69.48
0.67
7
A
ARG
22
-95.48
33.40
7
A
SER
23
70.97
30.21
8
A
THR
11
65.19
-8.70
8
A
ARG
22
-95.26
33.00
8
A
SER
23
83.05
36.85
9
A
THR
11
68.36
-1.89
9
A
TYR
13
55.86
17.75
9
A
CYS
20
-34.30
144.23
9
A
SER
23
85.69
19.04
10
A
THR
11
48.90
15.99
10
A
CYS
20
-27.23
132.59
10
A
ARG
22
-95.23
32.35
10
A
SER
23
80.41
32.03
11
A
THR
11
75.01
-20.92
11
A
TYR
13
49.08
28.50
11
A
ARG
22
-95.51
32.85
12
A
SER
19
-156.46
-15.81
12
A
CYS
20
-39.07
129.75
12
A
ARG
22
-95.34
32.95
13
A
THR
11
48.18
14.93
13
A
CYS
20
-38.28
142.82
13
A
ARG
22
-95.54
35.07
13
A
SER
23
62.15
64.10
14
A
CYS
8
-160.12
-166.95
14
A
THR
11
76.28
-25.87
14
A
SER
23
120.25
33.77
15
A
THR
11
77.66
-28.07
15
A
CYS
20
-34.40
140.68
15
A
ARG
22
-95.29
31.89
15
A
SER
23
59.63
79.76
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
phasing
X-PLOR
3.1
SVIB
N-TYPE CALCIUM CHANNEL BLOCKER, OMEGA-CONOTOXIN MVIIA NMR, 15 STRUCTURES
1
Y
N
A
LYS
10
A
LYS
10
HELX_P
A
SER
12
A
SER
12
5
1
3
disulf
2.020
A
CYS
1
A
SG
CYS
1
1_555
A
CYS
16
A
SG
CYS
16
1_555
disulf
2.022
A
CYS
8
A
SG
CYS
8
1_555
A
CYS
20
A
SG
CYS
20
1_555
disulf
2.016
A
CYS
15
A
SG
CYS
15
1_555
A
CYS
26
A
SG
CYS
26
1_555
covale
1.308
A
NH2
27
A
N
NH2
27
1_555
A
CYS
26
A
C
CYS
26
1_555
NEUROTOXIN
CONUS STRIATUS PEPTIDE SPECIFIC TO P/Q-TYPE VOLTAGE SENSITIVE CALCIUM CHANNEL, NEUROTOXIN
CXO6B_CONST
UNP
1
1
P28881
CKLKGQSCRKTSYDCCSGSCGRSGKC
1
26
1MVJ
1
26
P28881
A
1
1
26
3
anti-parallel
anti-parallel
A
CYS
20
A
CYS
20
A
GLY
21
A
GLY
21
A
GLY
24
A
GLY
24
A
CYS
26
A
CYS
26
A
GLN
6
A
GLN
6
A
CYS
8
A
CYS
8
BINDING SITE FOR RESIDUE NH2 A 27
Software
4
A
SER
19
A
SER
19
4
1_555
A
CYS
20
A
CYS
20
4
1_555
A
LYS
25
A
LYS
25
4
1_555
A
CYS
26
A
CYS
26
4
1_555
1
P 1